Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Relay Therapeutics Logo
Relay Therapeutics Growth Score
92
CB Rank
6751
Heat Score
91
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
Founded
obfuscation
PublicPost-IPO Equity Cambridge, Massachusetts, United States101-250 relaytx.com/
Biotechnology
Health Care
Therapeutics
Overview

Relay Therapeutics
Total Funding
obfuscation
Growth Score
92
Heat Score
91

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score92
-2 pts
in past quarter
Heat Score 91
25 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Relay Therapeutics

CB Rank
6751
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
Founded
obfuscation
PublicPost-IPO Equity Cambridge, Massachusetts, United States101-250 relaytx.com/
Biotechnology
Health Care
Therapeutics

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

  • Photo of Sanjiv Patel
    Sanjiv Patel: President and CEO
    Past Role: Allergan, Executive Vice President and Chief Strategy Officer
  • Photo of Mark Murcko
    Mark Murcko: Founder
    Past Role: Schrödinger, Consultant

Details

Legal Name Relay Therapeutics, Inc.
Operating Status Active
Stock Symbol  NASDAQ:RLAY
Company Type For Profit
Founders  Alexis Borisy, David E. Shaw, Dorothee Kern, Mark Murcko, Matthew Jacobson
About the Company

Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.The company's platform detects and characterizes interactions that occur anywhere on a protein and combines computational methods with experimental approaches across the fields of structural biology,

biophysics and chemistry, enabling pharmaceutical companies to solve and design therapies against complex diseases like cancer and others.

Phone Number (617)370-8837
Contact Email info@relaytx.com
Diversity Spotlight 
Women Founded
Predictions & Insights

Growth Insight

See this Growth Insight
Relay Therapeutics is
Lorem
 to be growing
Top Contributing Factors
Financial Growth

Products & Services

Dynamo Platform
A drug-discovery platform integrating computational and experimental methods to analyze protein motion for targeting previously difficult proteins.
RLY-2608
A mutant-selective PI3Kα inhibitor under clinical evaluation for treating PI3Kα-mutated solid tumors, advanced breast cancer, and PIK3CA-related vascular malformations.

Research & Development

Relay Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 8
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Relay Therapeutics Logo
Post-IPO Equity - Relay Therapeutics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Relay Therapeutics Logo
Post-IPO Equity - Relay Therapeutics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Relay Therapeutics Logo
Post-IPO Equity - Relay Therapeutics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Relay Therapeutics Logo
Post-IPO Equity - Relay Therapeutics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Relay Therapeutics Logo
Post-IPO Equity - Relay Therapeutics
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 8
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Relay Therapeutics Logo
Post-IPO Equity - Relay Therapeutics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Relay Therapeutics Logo
Post-IPO Equity - Relay Therapeutics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Relay Therapeutics Logo
Post-IPO Equity - Relay Therapeutics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Relay Therapeutics Logo
Post-IPO Equity - Relay Therapeutics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Relay Therapeutics Logo
Post-IPO Equity - Relay Therapeutics
—
obfuscation
— Post-IPO Equity

Investors

Investments

Number of Acquisitions 1

Investment Breakdown

Number of Acquisitions 1
Market Intelligence
People
View Profiles & Contacts
Headcount 101-250 Employee Profiles 18 Board Members and Advisors 12 Contacts 319

Employee Profiles

Board Members and Advisors

News

News and Press

News•May 27, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 22, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 21, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 21, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

5,444
7.23%
 in past month

IT Spend

$592.5KThis year, Relay Therapeutics is projected to spend $592.5K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Qlik Sense Logo
Qlik Sense
100
Broadcast Logo
Broadcast
100
Appian Corporation (APPN) Logo
Appian Corporation (APPN)
100

Actively Used Products

9Relay Therapeutics uses 9 technology products and services including HTML5, Google Analytics, and  jQuery, according to G2 Stack.

Active Website Tech Count

27Relay Therapeutics is actively using 27 technologies for its website, according to BuiltWith. These include HSTS, Apple Mobile Web Clips Icon, and  DNSSEC.

Total IP

48The intellectual property of Relay Therapeutics includes 42 registered patents primarily in the 'Organic Chemistry' category, according to IPqwery. Additionally, Relay Therapeutics has registered 6 trademarks with the most popular class being 'Scientific and technological services', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Relay Therapeutics's headquarters? Relay Therapeutics is located in Cambridge, Massachusetts, United States.Who invested in Relay Therapeutics? Relay Therapeutics has 13 investors including Nextech Invest and  Foresite Capital.When was the last funding round for Relay Therapeutics? Relay Therapeutics closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Relay Therapeutics's competitors? Alternatives and possible competitors to Relay Therapeutics may include Avenzo Therapeutics, Iambic, and  Roivant Sciences.How much funding has Relay Therapeutics raised to date? Relay Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|